Volume 10, Number 5—May 2004
Research
Laboratory Diagnosis of SARS
Table 2
No. positive specimens/no. tested for SARS-CoV (%) |
|||||||
---|---|---|---|---|---|---|---|
RT-PCR | Virus isolation | ||||||
Specimen type |
1 week |
2 weeks |
3–4 weeks |
1 week |
2 weeks |
3–4 weeks |
|
Respiratory |
|||||||
Tracheal aspirate |
1/2 (50.0) |
1/1 (100) |
4/4 (100) |
2/3 (66.7) |
1/1 (100) |
0/3 |
|
Pooled throat and nasal swabs |
6/17 (35.3) |
2/3 (66.7) |
2/5 (40.0) |
4/18 (22.2) |
0/3 |
0/1 |
|
Nasal swab |
9/27 (33.3) |
5/14 (35.7) |
1/17 (5.9) |
3/29 (10.3) |
2/18 (11.1) |
0/19 |
|
Nasopharyngeal aspirate |
39/138 (28.3) |
15/44 (34.1) |
6/10 (60.0) |
23/171 (13.5) |
6/54 (11.1) |
0/9 |
|
Throat swab |
5/19 (26.3) |
5/14 (35.7) |
3/10 (30.0) |
2/23 (8.7) |
0/15 |
1/15 (6.7) |
|
Throat washing |
4/40 (10.0) |
13/58 (22.4) |
1/48 (2.1) |
0/36 |
1/62 (1.6) |
0/51 |
|
Nonrespiratory |
|||||||
Rectal swab |
5/11 (45.5) |
2/10 (20.0) |
3/7 (42.9) |
0/14 |
0/12 |
0/35 |
|
Stool |
9/21 (42.9) |
17/25 (68.0) |
34/80 (42.5) |
2/24 (8.3) |
0/28 |
0/141 |
|
Urine | 2/75 (2.7) | 5/82 (6.1) | 6/54 (11.1) | 0/110 | 0/86 | 2/76 (2.6) |
aSARS-CoV, severe acute respiratory syndrome–associated coronavirus; RT-PCR, reverse transcription–polymerase chain reaction.
Page created: February 22, 2011
Page updated: February 22, 2011
Page reviewed: February 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.